Antiprothrombin antibody: Why do we need more assays?

Lupus

Volumn 19, Issue 4, 2010, Pages 436-439

  Atsumi, T ^a   Koike, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiphospholipid syndrome; Antiprothrombin antibody; Lupus anticoagulant; Phosphatidylserine; Thrombosis

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE; PROTHROMBIN; PROTHROMBIN ANTIBODY;

ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; LABORATORY TEST; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASES; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUPUS COAGULATION INHIBITOR; PHOSPHATIDYLSERINES; PROTHROMBIN; SENSITIVITY AND SPECIFICITY;

EID: 77951221087     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310361487     Document Type: Review

References (11)

1. Arvieux J., Darnige L., Caron C., Reber G., Bensa JC, Colomb MG Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulant. Thromb Haemost 1995 ; 74: 1120-1125.
2. Galli M., Beretta G., Daldossi M., Bevers EM, Barbui T. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1997 ; 77: 486-491. (Pubitemid 27121014)
3. Rauch J., Tannenbaum M., Neville C., Fortin PR Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin. Thromb Haemost 1998 ; 80: 936-941. (Pubitemid 28556696)
4. McDonald JF, Shah AM, Schwalbe RA, Kisiel W., Dahlback B., Nelsestuen GL Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site. Biochemistry 1997 ; 36: 5120-5127. (Pubitemid 27199727)
5. Bevers EM, Zwaal RF, Willems GM The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin. Clin Immunol 2004 ; 112: 150-160.
6. Pierangeli SS, Goldsmith GH, Branch DW, Harris EN Antiphospholipid antibody: functional specificity for inhibition of prothrombin activation by the prothrombinase complex. Br J Haematol 1997 ; 97: 768-774.
7. Simmelink MJ, Horbach DA, Derksen RH, et al. Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces. Br J Haematol 2001 ; 113: 621-629.
8. Sakai Y., Atsumi T., Ieko M., et al. The effects of phosphatidylserine- dependent antiprothrombin antibody on thrombin generation. Arthritis Rheum 2009 ; 60: 2457-2467.
9. Galli M., Luciani D., Bertolini G., Barbui T. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003 ; 102: 2717-2723. (Pubitemid 37248837)
10. Atsumi T., Ieko M., Bertolaccini ML, et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000 ; 43: 1982-1993.
11. Atsumi T., Amengual O., Yasuda S., Koike T. Antiprothrombin antibodies-are they worth assaying? Thromb Res 2004 ; 114: 533-538. (Pubitemid 39422588)